Selective dopamine D4 receptor antagonists

By Sanner M.A.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Synthesis and Structure-Activity Relationships of 4,10-Dihydro-4-oxo-4HImidazo[ 1,2-a]Indeno[1,2-e]Pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with In Vivo Activity

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 2, 2004-02 ,pp. : 123-140

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-activity relationships of competitive NMDA receptor antagonists

By Cheung N.S.   O'Callaghan D.   Ryan M.C.   Dutton R.   Wong M.G.   Beart P.M.  

European Journal of Pharmacology, Vol. 313, Iss. 1, 1996-10 ,pp. : 159-162

Elsevier

Access to resources Recommend Favorite

Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships

By  

Current Medicinal Chemistry, Vol. 7, Iss. 2, 2000-02 ,pp. : 211-247

Bentham Science Publishers

Access to resources Recommend Favorite

Selective endothelin A receptor antagonists. 2. Discovery and structure-activity relationships of 5-ketopentanoic acid derivatives

By Astles P.   Brown T.   Harris N.   Harper M.   McCarthy C.   Porter B.   Smith C.   Walsh R.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 6, 1997-06 ,pp. : 515-522

Elsevier

Access to resources Recommend Favorite